Role of hindbrain melanocortin-4 receptor activity in controlling cardiovascular and metabolic functions in spontaneously hypertensive rats

Journal of Hypertension

Volumn 33, Issue 6, 2015, Pages 1201-1206

  Do Carmo, Jussara M ^a   Da Silva, Alexandre A ^a   Hall, John E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

blood pressure; central nervous system; food intake; heart rate; melanocortin system

Indexed keywords

INSULIN; LEPTIN; MELANOCORTIN 4 RECEPTOR; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; INTERMEDIN; MELANOCORTIN 3 RECEPTOR;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FOOD INTAKE; HEART RATE; HYPERPHAGIA; INCREASED APPETITE; INSULIN BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; RHOMBENCEPHALON; SPONTANEOUSLY HYPERTENSIVE RAT; TELEMETRY; WEIGHT GAIN; ANIMAL; ANTAGONISTS AND INHIBITORS; APPETITE; BLOOD; EATING; HYPERTENSION; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR KYOTO RAT;

ANIMALS; APPETITE; BLOOD PRESSURE; BODY WEIGHT; EATING; HEART RATE; HYPERTENSION; INSULIN; LEPTIN; MALE; MELANOCYTE-STIMULATING HORMONES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4; RHOMBENCEPHALON;

EID: 84929471384     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000530     Document Type: Article

References (20)

1. Fan W, Dinulescu DM, Butler AA, Zhou J, Marks DL, Cone RD. The central melanocortin system can directly regulate serum insulin levels. Endocrinology 2000; 141:3072-3079.
2. Hagan MM, Rushing PA, Schwartz MW, Yagaloff KA, Burn P, Woods SC, Seeley RJ. Role of the CNS melanocortin system in the response to overfeeding. J Neurosci 1999; 19:2362-2367.
3. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88:131-141.
4. Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009; 360:44-52.
5. Tallam LS, da Silva AA, Hall JE. Melanocortin-4 receptormediates chronic cardiovascular andmetabolic actionsof leptin. Hypertension2006; 48:58-64.
6. da Silva AA, do Carmo JM, Kanyicska B, Dubinion J, Brandon E, Hall JE. Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats. Hypertension 2008; 51:884-890.
7. da Silva AA, do Carmo JM, Dubinion JH, Bassi M, Mokwtarpouriani K, Hamza SM, Hall JE. Chronic central nervous system MC3/4R blockade attenuates hypertension induced by nitric oxide synthase inhibition but not angiotensin II infusion. Hypertension 2014; 65:171-177.
8. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 2005; 123:493-505.
9. do Carmo JM, da Silva AA, Rushing JS, Pace B, Hall JE. Differential control of metabolic and cardiovascular functions by melanocortin-4 receptors in proopiomelanocortin neurons. Am J Physiol Regul Integr Comp Physiol 2013; 305:R359-368.
10. do Carmo JM, Hall JE, da Silva AA. Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats. Am J Physiol Heart Circ Physiol 295:2008:H1974-H1981.
11. Valenti VE, De Abreu LC, Sato MA, Saldiva PH, Fonseca FL, Giannocco G, et al. Central N-acetylcysteine effects on baroreflex in juvenile spontaneously hypertensive rats. J Integr Neurosci 2011; 10:161-176.
12. Dunbar JC, Lu H. Proopiomelanocortin (POMC) products in the central regulation of sympathetic and cardiovascular dynamics: studies on melanocortin and opioid interactions. Peptides 2000; 21:211-217.
13. Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 1999; 33:542-547.
14. Rahmouni K, Haynes WG, Morgan DA, Mark AL. Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. J Neurosci 2003; 23:5998-6004.
15. Kuo JJ, da Silva AA, Tallam LS, Hall JE. Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation. Hypertension 2004; 43:370-375.
16. Greenfield JR. Melanocortin signalling and the regulation of blood pressure in human obesity. J Neuroendocrinol 2011; 23:186-193.
17. do Carmo JM, Sessums P, Ebaady S, Freeman J, Hall JE, da Silva AA. Melanocortin-4 receptors in the PVN and RVLM are important in mediating the cardiovascular responses to acute stress [Abstract]. FASEB J 2014; S28:686.7.
18. Kuo JJ, Silva AA, Hall JE. Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function. Hypertension 2003; 41:768-774.
19. Li G, Mobbs CV, Scarpace PJ. Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity, and improved insulin sensitivity in genetically obese Zucker rats. Diabetes 2003; 52:1951-1957.
20. Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L. Central melanocortin receptors regulate insulin action. J Clin Investig 2001; 108:1079-1085.